1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Curevo Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older Amezosvatein Antigen High Dose Arm A, Amezosvatein Antigen Low Dose Arm B, Shingrix - Herpes Zoster, Shingles | Phase 2 | Active not recruiting | Curevo Inc | 1516 | 2022-02-02 | 2025-09-30 |
| Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects CRV 101, Placebo - Herpes Zoster, Varicella Zoster | Phase 1 | Completed | Curevo Inc | 90 | 2019-01-03 | 2021-02-11 |
Herpes Zoster (2) · Chickenpox (1)
Sodium Chloride (1)
United States (2)
Corey Casper, MD (1) · Guy De La Rosa, MD (1) · John E Ervin, MD (1) · Lisa Shelton (1) · Lisa Shelton, ARNP (1)